Cautious continuation: hepatic immune-related adverse events as a beacon for immune checkpoint inhibitor efficacy

Yuhang Zhou1, Chang Liu2

  • 1Department of Pharmacology, Cancer Hospital of China Medical University; Cancer Hospital of Dalian University of Technology; Liaoning Cancer Hospital & Institute, Shenyang, 110042, Liaoning, China.

Hepatology International
|November 17, 2025
PubMed
Abstract

No abstract available in PubMed .